Marburg I Polymorphism (G511E) in Adults with Deep Vein Thrombosis
Open Access
- 12 June 2019
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 36 (1) , 183-186
Abstract
The Marburg I polymorphism (G511E) in FSAP gene was listed as one of the risk factor for idiopathic DVT among the western population. The frequency of Marburg I polymorphism in India is presently not known. Fifty DVT cases and 50 healthy controls were tested for Marburg I polymorphism using ARMS-PCR technique. The thrombophilic risk factors (Protein C, Protein S, Antithrombin III, Factor V Leiden and antiphospholipid antibodies) were also determined. Marburg I polymorphism (heterozygous) was found in 2 patients (4%) but not in control subjects. These two cases did not have any other thrombophilia markers. Among the thrombophilic markers, heterozygous FVL mutation, PS, PC, AT deficiencies and antiphospholipid antibodies were seen in 10%, 10%, 6%, 6% and 8% of the patients respectively. The controls showed only the presence of antiphospholipid antibodies in 6% of subjects. Marburg I polymorphism among Indians DVT patients was determined for the first time. Its incidence was found in 4% of cases and not in controls. Although not statically significant this may be considered as one of the contributory risk factors for the development of DVT. A larger study is required for the validation of data.Keywords
Funding Information
- Department of Science, Engineering and Technology, UT-Chandigarh (S&T/Sanc/06/2014/456-461 dated 5.6.14)
- Medical Education and Research Cell, PGIMER, Chandigarh (2014-16)
This publication has 17 references indexed in Scilit:
- Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolismBlood Coagulation & Fibrinolysis, 2016
- Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North IndiaInternational Journal of Rheumatic Diseases, 2014
- The G534E-polymorphism of the gene encoding the Factor VII-activating protease is a risk factor for venous thrombosis and recurrent eventsThrombosis Research, 2012
- Differences in Etiological and Clinical Manifestations in Upper Extremity and Lower Limb Deep Venous Thrombosis Patients From IndiaClinical and Applied Thrombosis/Hemostasis, 2009
- Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western IndiaThrombosis Journal, 2007
- The Marburg I polymorphism of factor VII-activating protease is not associated with venous thrombosisBlood, 2005
- Marburg I polymorphism of factor VII–activating protease is associated with idiopathic venous thromboembolismBlood, 2005
- Heterogeneous distribution of factor V Leiden in patients from north India with venous thromboembolismJournal of Thrombosis and Haemostasis, 2003
- A protease isolated from human plasma activating Factor VII independent of tissue factorBlood Coagulation & Fibrinolysis, 1999
- Epidemiology of Factor V Leiden: Clinical ImplicationsSeminars in Thrombosis and Hemostasis, 1998